Develops nutraceuticals and cannabinoids for pain and neurological disorders.
Mar 2024Revenue $2.76M/yrExpenses $8.08M/yr
No trendCash runway ≈ 1 month from Mar 2024
Figures by year
When will Panacea Life Sciences Holdings be profitable?
Its figures don’t show a steady enough trend to project a date. In the 12 months to Mar 2024, revenue was $2.76M and expenses $8.08M.
| Fiscal year to | Revenue | Expenses | Operating profit |
|---|---|---|---|
| Dec 2023 | $2.38M | $7.93M | −$5.55M |
| Dec 2022 | $1.63M | $7.28M | −$5.65M |
| Dec 2021 | $2.06M | $8.00M | −$5.94M |
| Dec 2020 | $9.02M | $14.3M | −$5.26M |
| Dec 2019 | $346K | $11.0M | −$10.7M |
| Dec 2018 | $0.00 | $2.44M | −$2.44M |
| Dec 2017 | $0.00 | $3.12M | −$3.12M |
| Dec 2016 | $0.00 | $1.60M | −$1.60M |
| Dec 2015 | $213 | $389K | −$389K |
| Dec 2014 | $852 | $421K | −$420K |
When the cash runs out, on the chart. A red line at the date the company’s cash would run out at its latest burn, so you can see whether it gets to break-even first. Part of a subscription.